213 related articles for article (PubMed ID: 20813773)
21. Internet-based cognitive testing in multiple sclerosis.
Younes M; Hill J; Quinless J; Kilduff M; Peng B; Cook SD; Cadavid D
Mult Scler; 2007 Sep; 13(8):1011-9. PubMed ID: 17623730
[TBL] [Abstract][Full Text] [Related]
22. The cognitive burden of multiple sclerosis in children.
Banwell BL; Anderson PE
Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431
[TBL] [Abstract][Full Text] [Related]
23. Neuropsychological assessment: experimental and clinical research.
Falautano M
Neurol Sci; 2010 Nov; 31(Suppl 2):S223-6. PubMed ID: 20640469
[TBL] [Abstract][Full Text] [Related]
24. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
[TBL] [Abstract][Full Text] [Related]
25. Cognitive functioning in children and adolescents with multiple sclerosis.
MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB
Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734
[TBL] [Abstract][Full Text] [Related]
26. Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis.
Christodoulou C; Melville P; Scherl WF; Morgan T; MacAllister WS; Canfora DM; Berry SA; Krupp LB
J Int Neuropsychol Soc; 2005 Sep; 11(5):614-9. PubMed ID: 16212689
[TBL] [Abstract][Full Text] [Related]
27. [Neuropsychological impairments in non-demented patients with multiple sclerosis].
Smilković P; Ocić G; Filipović S; Lević Z; Drulović J
Srp Arh Celok Lek; 1994; 122(1-2):19-21. PubMed ID: 17972795
[TBL] [Abstract][Full Text] [Related]
28. Validity of the Italian multiple sclerosis neuropsychological screening questionnaire.
Migliore S; Landi D; Proietti F; D'Aurizio G; Squitieri F; Mataluni G; Nicoletti CG; Curcio G; Marfia GA
Neurol Sci; 2021 Nov; 42(11):4583-4589. PubMed ID: 33651198
[TBL] [Abstract][Full Text] [Related]
29. [Quality of life and multiple sclerosis: validation of the french version of the self-questionnaire (SEP-59)].
Vernay D; Gerbaud L; Biolay S; Coste J; Debourse J; Aufauvre D; Beneton C; Colamarino R; Glanddier PY; Dordain G; Clavelou P
Rev Neurol (Paris); 2000 Mar; 156(3):247-63. PubMed ID: 10740096
[TBL] [Abstract][Full Text] [Related]
30. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
[TBL] [Abstract][Full Text] [Related]
31. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
[TBL] [Abstract][Full Text] [Related]
32. Cognitive functioning in children with multiple sclerosis.
Montiel-Nava C; Peña JA; González-Pernía S; Mora-La Cruz E
Mult Scler; 2009 Feb; 15(2):266-8. PubMed ID: 18922833
[TBL] [Abstract][Full Text] [Related]
33. Neuropsychological investigations of multiple sclerosis: a clinical perspective.
O'Connor MG
Clin Neurosci; 1994; 2(3-4):225-8. PubMed ID: 7749892
[TBL] [Abstract][Full Text] [Related]
34. [The possibilities of neuropsychological rehabilitation in multiple sclerosis].
Rosti-Otajärvi E; Hämäläinen P
Duodecim; 2010; 126(24):2845-52. PubMed ID: 21268907
[TBL] [Abstract][Full Text] [Related]
35. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
Dusankova JB; Kalincik T; Havrdova E; Benedict RH
Clin Neuropsychol; 2012; 26(7):1186-200. PubMed ID: 23034066
[TBL] [Abstract][Full Text] [Related]
36. [Impairment of cognitive processes in patients with multiple sclerosis].
Szafraniec L; Czernicki J
Przegl Lek; 1997; 54(7-8):572-5. PubMed ID: 9480474
[No Abstract] [Full Text] [Related]
37. Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline.
Morrow SA; Drake A; Zivadinov R; Munschauer F; Weinstock-Guttman B; Benedict RH
Clin Neuropsychol; 2010 Oct; 24(7):1131-45. PubMed ID: 20830649
[TBL] [Abstract][Full Text] [Related]
38. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
[TBL] [Abstract][Full Text] [Related]
39. Specific impairments of emotion perception in multiple sclerosis.
Phillips LH; Henry JD; Scott C; Summers F; Whyte M; Cook M
Neuropsychology; 2011 Jan; 25(1):131-6. PubMed ID: 21090898
[TBL] [Abstract][Full Text] [Related]
40. T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis.
Bagnato F; Salman Z; Kane R; Auh S; Cantor FK; Ehrmantraut M; Gallo A; Ikonomidou VN; Ohayon J; Pellicano C; Stern SK; McFarland HF
Mult Scler; 2010 Oct; 16(10):1203-12. PubMed ID: 20699284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
